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We evaluated the annual rate (cases/10,000 hospital-
izations) of pediatric hospitalizations with Clostridium dif-
ﬁ  cile infection (CDI; International Classiﬁ  cation of Diseases, 
9th revision, clinical modiﬁ  cation code 008.45) in the United 
States. We performed a time-series analysis of data from 
the Kids’ Inpatient Database within the Health Care Cost 
and Utilization Project during 1997–2006 and a cross-sec-
tional analysis within the National Hospital Discharge Sur-
vey during 2006. The rate of pediatric CDI-related hospital-
izations increased from 7.24 to 12.80 from 1997 through 
2006; the lowest rate was for children <1 year of age. Al-
though incidence was lowest for newborns (0.5), incidence 
for children <1 year of age who were not newborns (32.01) 
was similar to that for children 5–9 years of age (35.27), 
which in turn was second only to incidence for children 1–4 
years of age (44.87). Pediatric CDI-related hospitalizations 
are increasing. A better understanding of the epidemiology 
and outcomes of CDI is urgently needed.
T
he epidemiology of Clostridium difﬁ  cile infection 
(CDI) has been shifting over the past decade. Since 
2000, the molecular evolution of the hypervirulent toxi-
genic bacterial strain BI/NAP1/027, which causes severe 
disease in massive outbreak settings, has been well docu-
mented (1–4). Furthermore, the increasing detection of this 
strain in the United States and other countries coincides 
with reports of increasing hospitalizations either resulting 
from or complicated by CDI and associated with increased 
case-fatality rates (5–7). Although in the past it was not 
thought to affect pediatric populations substantially, CDI 
has more recently been implicated as an increasingly prev-
alent diarrheal pathogen in children (8–10). Moreover, 
evidence suggests that a large proportion of pediatric CDI 
cases are community-acquired infections and that many of 
these infections lack the traditional risk factor of exposure 
to antimicrobial drugs (11–13). These changes in the epide-
miology of pediatric CDI, although not deﬁ  nitively caused 
by the BI/NAP1/027 strain, are likely related to this strain 
because at least 2 reports suggest a high prevalence (10%–
38%) of this strain in pediatric CDI populations and a 4× 
increase in complication rates associated with this strain 
compared with other strains (14,15).
Current age-speciﬁ   c epidemiology of CDI among 
children remains poorly studied. Literature predating the 
emergence of the epidemic strain suggests that although up 
to 67% of all neonates (i.e., <1 month of age) become colo-
nized with C. difﬁ  cile in the perinatal period, they do not 
appear to be at risk for the development of CDI-associated 
symptoms (16). Conversely, children 1 month–2 years of 
age, although less likely to become colonized with this bac-
terium, are more likely to have attendant disease (16). Fi-
nally, children 3–18 years of age have been reported to have 
similar risk for CDI as that seen in adults (16). Because the 
epidemiology of CDI is changing rapidly in children and 
adults, we examined age-speciﬁ   c trends in CDI-related 
hospitalizations in the US population <18 years of age.
Materials and Methods
To characterize the epidemiology of CDI-related hos-
pitalizations among US children, we performed 2 analyses 
using 2 databases. These databases are based on adminis-
trative coding, and consistency in results obtained from 
>1 data source potentially indicates a higher chance of 
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accuracy. In addition, the format in which we analyzed 1 
of the databases (Kids’ Inpatient Database [KID]) did not 
enable separating newborn discharges (deﬁ  ned as those 
hospitalizations during which the child was born) from 
those of other children <1 year of age. Because newborns 
represent a unique population prone to colonization but 
not overt disease, we chose a second database that en-
ables separate analysis of newborns (National Hospital 
Discharge Survey [NHDS]).
The ﬁ  rst analysis was a time-series analysis of all 
CDI-related hospitalizations among US children between 
1997 and 2006 based on the data from KID within the 
Healthcare Cost and Utilization Project (HCUP) adminis-
tered by the Agency for Healthcare Research and Quality 
(Rockville, MD, USA). This type of longitudinal analysis 
is useful for tracking disease patterns over long periods. 
KID was speciﬁ  cally designed to identify, track, and an-
alyze national trends in healthcare use, access, charges, 
quality, and outcomes; in 2006, it included data from 
3,739 hospitals from 38 states in the United States (17). 
Complex survey methods exist to develop national and 
regional estimates for conditions addressed in the data-
base. The Agency for Healthcare and Research Quality 
assesses completeness and data quality, and documenta-
tion is provided with the dataset. Data quality checks are 
limited to logical issues (e.g., birth date precedes age at 
hospital admission, excessively low total charges or long 
length of stay, age <10 years or >55 years on a maternal 
record, and mixed neonatal and maternal records), i.e., no 
chart reviews are undertaken by the agency.
For the current study, all data were derived in aggre-
gate from the publicly available HCUPNet website (18). 
Because the years for which data were available were 1997, 
2000, 2003, and 2006, our observations were limited to these 
periods. We examined the annual incidence of CDI-related 
hospitalizations on the basis of the International Classiﬁ  ca-
tion of Diseases, 9th revision, clinical modiﬁ  cation (ICD-
9-CM), code 008.45 (intestinal infection with C. difﬁ  cile) 
as a proportion of all hospitalizations. We additionally de-
termined the time trends for CDI as the principal discharge 
diagnosis in this population. Finally, to understand better 
the context of increasing CDI-related hospitalizations, we 
examined trends in hospitalizations related to other diar-
rheal diseases, speciﬁ  cally Salmonella (ICD-9-CM 00.30), 
rotavirus (ICD-9-CM 008.61), viral enteritis (ICD-9-CM 
008.8), and other infectious enteritides (ICD-9-CM codes 
009.0–009.3, 487.8).
The second analysis was a cross-sectional character-
ization of all CDI hospitalizations for patients <18 years of 
age in 2006 reported in the NHDS collected by the Centers 
for Disease Control and Prevention (Atlanta, GA, USA) 
and available as a public utility ﬁ  le from the National Cen-
ter for Health Statistics (NCHS) (Hyattsville, MD, USA) 
(19). NHDS covers discharges from ≈500 noninstitutional, 
nonfederal, short-stay hospitals in the United States. The 
3-stage survey design enables balanced geographic repre-
sentation; data are abstracted either manually or electroni-
cally for an ≈1% representative sample of all US hospital-
izations. To ensure quality and completeness of the data, 
NCHS at the Centers for Disease Control and Prevention 
conducted studies in the late 1970s. These surveys indicat-
ed that the NHDS data met the general standards for quality 
set by NCHS (20).
Results
According to data from KID, the national number 
of pediatric CDI-related hospitalizations increased from 
4,626 in 1997 to 8,417 in 2006 (Table 1). This change cor-
responded to an increased rate from 7.24/10,000 hospital-
izations in 1997 to 12.80/10,000 hospitalizations in 2006 
and represented a crude 9.0% per year increase. Although 
the group <1 year of age consistently accounted for the 
largest proportion of all pediatric CDI-related hospitaliza-
tions (Table 1), this group accounted for the lowest rate 
of CDI hospitalizations across the entire group of children; 
the highest incidence in all 4 years was detected in the 
group 1–4 years of age (Figure 1). The proportion of all 
CDI-related hospitalizations that had CDI listed as the prin-
cipal discharge diagnosis remained essentially stable over 
the period examined (Table 1). Among other infectious 
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Table 1. Clostridium difficile infection–related hospitalizations, by year and age group, HCUP and KID, United States* 
Characteristic 1997 2000 2003 2006 
Age group, y
 <1  1,269  1,444  1,586  2,269 
  1–4  1,480 1,453 1,880 2,587 
 5–9  699 673 934 1,255 
 10–14  602 815 920 1,197 
 15–17  576 574 716 1,110 
All 4,625 4,960 6,035 8,417 
% CDIs as principal diagnosis  0.31 0.29 0.27 0.29
*HCUP, Health Care Utilization Project; KID, Kids’ Inpatient Database; CDIs, C. difficile infections. The sums of individual age groups may not add up to the
total cases because numbers represent rounded values of weighted estimates.   RESEARCH
gastroenteritis-related hospitalizations, only rotavirus had 
a similar upward trajectory during this period (Figure 2).
Characteristics of CDI-related and nonrelated hospital-
izations in the NHDS are shown in Table 2. The overall rate 
of pediatric CDI hospitalizations was 14.03/10,000 hospi-
talizations, and the age-speciﬁ  c rate did not differ substan-
tially from that seen in the KID 2006 database (Figure 3). 
Although the newborn group, deﬁ  ned as infants whose hos-
pitalizations originated at their birth, in NHDS represented 
57.4% of all children hospitalized in 2006 and 84.2% of 
all children <1 year of age hospitalized, it had the lowest 
CDI rate of all pediatric age groups; the annual rate was 
0.5/10,000 hospitalizations (Figure 3). Although the groups 
1–4 and 5–9 years of age had the ﬁ  rst (44.87/10,000) and 
second (35.27/10,000) highest rates of CDI hospitaliza-
tions, the third highest rate was seen in the non-newborn, 
<1 year of age group (32.01/10,000). The groups 10–14 and 
15–17 years of age had the lowest rates of CDI hospitaliza-
tions in the pediatric cohort (Figure 3). There were no ob-
served meaningful age-speciﬁ  c or sex-speciﬁ  c differences 
between the populations represented in the 2 data sources.
Discussion
We found that CDI-related hospitalizations as a pro-
portion of all hospitalizations among US children in-
creased dramatically between 1997 and 2006, from 7.24 
to 12.80/10,000 hospitalizations. Most of this increase 
occurred between 2000 and 2006, which possibly reﬂ  ects 
spread of the new C. difﬁ  cile strain into medical institu-
tions. Consistent with ﬁ  nding from previous studies, chil-
dren 1–4 years of age were as a group most likely to have 
a hospitalization that was CDI related, and newborns were 
the least likely. Such a low rate in newborns is consistent 
with long-standing recommendations against routine test-
ing of children <1 year of age (21). This rate, rather than 
representing a truly low risk for CDI in this age group, may 
be the result of an inﬂ  ated denominator, given that most 
births in the United States occur in a hospital setting. In 
contrast, non-newborn infants (i.e., those <1 year of age and 
not meeting the newborn deﬁ  nition) had the second high-
est rate of CDI-related hospitalizations. In addition to the 
overall increase in pediatric CDI-related hospitalizations, 
there was a coincident increase in hospitalizations either 
resulting from or complicated by rotavirus infection.
Several of these ﬁ  ndings are consistent with other re-
cent epidemiologic and microbiology-based investigations. 
For example, Klein et al. examined billing records for the 
testing of diarrheal stool specimens from children who 
came to the emergency department at a children’s hospi-
tal between 1998 and 2001 and identiﬁ  ed C. difﬁ  cile toxin 
in 6.7% (8). However, viral pathogens were isolated from 
33% of the samples. A more recent study tracked changes 
between 2001 and 2006 in the epidemiology of C. difﬁ  cile 
toxin testing performed on children at 1 academic medical 
center (11). The proportion of children <2 years of age who 
were positive increased from 46% to 64%, and there was a 
substantial increase in the incidence of community-onset 
infections and a concomitant decrease in hospital-onset in-
fections. Interestingly, 43% of all patients had no recent 
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Figure 1. Age-speciﬁ  c incidence of patients with Clostridium difﬁ  cile 
infection (CDI) per 10,000 hospitalizations, Health Care Utilization 
Project Kids’ and Inpatient Database, United States, 1997–2006.
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Figure 2. Incidence of infectious diarrhea hospitalizations per 
10,000 all-cause hospitalizations, Health Care Utilization Project 
and Kids’ Inpatient Database, United States, 1997–2006. CDI, 
Clostridium difﬁ  cile infection.C. difﬁ  cile in Hospitalized Children
history of exposure to antimicrobial drugs (11). Kim et al. 
estimated the rate of CDI in 22 US children’s hospitals and 
also found a steady increase from 4.4 cases/10,000 patient-
days in 2001 to 6.5 cases/10,000 patient-days in 2006 (9).
The role of C. difﬁ  cile in the pathogenesis of disease 
among non-newborn children <1 year of age remains per-
plexing. Because of historically low rates of pseudomem-
branous colitis (the characteristic pathologic lesion caused 
by toxins A and B) among infants and high rates of asymp-
tomatic C. difﬁ  cile carriage in neonates, it has been rec-
ommended that laboratory testing for CDI not be routinely 
performed for children <1 year of age (21). However, in the 
study by Kim et al., in which tests for C. difﬁ  cile laboratory 
assays were combined with ICD-9-CM discharge diagno-
ses, 26% of all CDI cases were identiﬁ  ed in infants and 
5% in neonates (9). Although rates increased from 2001 
through 2006 for children 1–5 years of age (from 0.7 to 
1.3 cases/1,000 hospitalizations; p = 0.04) and those 5–17 
years of age (from 1.2 to 1.8/1,000 hospitalizations; p = 
0.03), these rates did not change for the group <1 year of 
age (from 3.1 to 3.0/1,000 hospitalizations).
Our data, which are more broadly representative of 
all pediatric admissions in the United States, have similar 
trends between 2000 and 2006 for children 1–4 years of age 
(from 2.68 to 4.52/1,000 hospitalizations) and those 5–17 
years of age (from 1.62 to 2.86/1,000 hospitalizations). In 
contrast, the <1 year age group rates from our time series 
were an order of magnitude lower in 2000 and 2006. How-
ever, the rate for non-newborn children <1 year of age in 
our 2006 cross-sectional study (3.20/1,000 hospitalizations) 
was comparable with that observed by Kim et al. (9). The 
lower overall rate for children <1 year of age from our data 
likely reﬂ  ects that healthy newborns have an exceedingly 
low risk for CDI and that although it is unlikely for these 
children to end up at a children’s hospital unless peripartum 
problems are encountered, neonates account for >80% of 
all hospitalized children <1 year of age in the HCUP and 
KID databases.
We could not determine whether the relatively high 
rate of CDI-related hospitalizations among non-newborn in-
fants represents predominantly true disease or colonization. 
Although more speciﬁ  c than recovery of a toxin-producing 
strain from culture, even the detection of free toxins A, B, 
or both in the stool of a symptomatic infant does not ensure 
a pathogenic role for C. difﬁ  cile, especially if another cause 
for diarrhea can be identiﬁ  ed. Rates of hospitalizations for 
rotavirus infections have exhibited a similar increase as 
those with CDI between 1997 and 2006. Although 2 recent 
analyses of discharge data for adults suggest that non-CDI 
causes of diarrhea are not likely leading to a reporting bias 
as the explanation for the observed increase in CDI rates 
(22,23), the situation may be different for children in whom 
rotavirus is a serious pathogen and related hospitalizations 
are clearly increasing. Although Kim et al. did not report an 
increase in the frequency of testing for C. difﬁ  cile in their 
study, our ﬁ  ndings implicate this ﬁ  nding as a distinct pos-
sibility that needs to be investigated further (9).
Our study has several limitations. First, case identiﬁ  ca-
tion was based on administrative coding, thus predisposing 
to misclassiﬁ  cation. However, the degree of misclassiﬁ  ca-
tion may not be substantial because multiple studies have 
shown the ICD-9-CM code 008.45 to be a relatively accu-
rate way to identify CDI (24–26). Second, because we had 
no clinical data available, we could not distinguish stool 
colonization from CDI infection. Third, we were unable to 
distinguish community-acquired from healthcare-associat-
ed disease.
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Table 2. Demographic characteristics for CDIs, National Hospital 
Discharge Survey, United States, 2006* 
Characteristic
No. (%) 
CDIs
No. (%)  
non-CDIs 
All pediatric hospitalizations  98 69,651 
Age, y 
 Newborn  2 40,022 
  <1 but not newborn  24 7,474 
 1–4  32 7,099 
 5–9  16 4,521 
 10–14  13 4,943 
 15–17  11 5,690 
Sex
  M  48 (49.0)  35,941 (51.5) 
  F  50 (51.0)  33,808 (48.5) 
Race
  Caucasian  59 (60.2)  39,457 (52.3) 
  African American  12 (12.2)  9,602 (13.8) 
  Other  7 (7.1)  5,589 (8.0) 
  Not stated  20 (20.4)  18,069 (26.0) 
*CDIs, Clostridium difficile infections. 
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Figure 3. Age-speciﬁ   c incidence of Clostridium difﬁ  cile infection 
(CDI) hospitalizations, National Hospital Discharge Survey, United 
States, 2006. *Newborn (i.e., during hospitalization for birth); †not 
newborn (i.e., during subsequent hospitalization).RESEARCH
However, our study has several strengths. Because we 
explored 2 databases and discovered results that are highly 
consistent not only with each other but with those of previ-
ous recent investigations, we have augmented the accuracy 
of estimates of pediatric CDI incidence (9). In addition, our 
data are generalizable to most US-based institutions that 
care for the pediatric populations. This generalizability sets 
our results apart from those reported previously because 
they were limited to the highly specialized setting of chil-
dren’s hospitals (8,9,11).
In summary, the incidence of CDI in the pediatric 
population appears to be increasing in US hospitals. A re-
porting bias for diarrheal diseases may play a role in this 
trend given the concomitant increase in rotavirus-related 
hospitalizations we identiﬁ  ed. Future data may clarify this 
ﬁ  nding because widespread immunization with available 
rotavirus vaccines may soon lead to reduced incidence of 
related hospitalizations. The low incidence of CDI-related 
hospitalizations among newborns reﬂ  ects current recom-
mendations against routine testing and may support the 
concept that C. difﬁ  cile does not cause disease among neo-
nates. In contrast, the relatively high rate of CDI-related 
hospitalizations among non-newborn infants indicates an 
urgent need for studies to determine how often C. difﬁ  cile 
causes true disease in this population.
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